These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8438342)

  • 1. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
    Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N
    Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon.
    Cooper DK; Ye Y; Niekrasz M; Kehoe M; Martin M; Neethling FA; Kosanke S; DeBault LE; Worsley G; Zuhdi N
    Transplantation; 1993 Oct; 56(4):769-77. PubMed ID: 8212194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation.
    Cooper DK; Ye Y; Kehoe M; Niekrasz M; Rolf LL; Martin M; Baker J; Kosanke S; Zuhdi N; Worsley G
    Transplant Proc; 1992 Apr; 24(2):566-71. PubMed ID: 1566432
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts.
    Rose AG; Cooper DK; Human PA; Reichenspurner H; Reichart B
    J Heart Lung Transplant; 1991; 10(2):223-34. PubMed ID: 2031919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antiendothelial antibody in primate cardiac xenograft rejection.
    O'Hair DP; McManus RP; Johnson CP; Scott JP
    Transplant Proc; 1992 Apr; 24(2):506-7. PubMed ID: 1566407
    [No Abstract]   [Full Text] [Related]  

  • 8. ABO-incompatibility in solid organ transplantation.
    Rydberg L
    Transfus Med; 2001 Aug; 11(4):325-42. PubMed ID: 11532188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival.
    Fischel RJ; Bolman RM; Platt JL; Najarian JS; Bach FH; Matas AJ
    Transplant Proc; 1990 Jun; 22(3):1077-8. PubMed ID: 2190373
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the pig to human xenograft reaction, using soluble Gal alpha 1-3Gal and Gal alpha 1-3Gal beta 1-4GlcNAc.
    Cairns T; Lee J; Goldberg L; Cook T; Simpson P; Spackman D; Palmer A; Taube D
    Transplantation; 1995 Dec; 60(11):1202-7. PubMed ID: 8525510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of antibody removal before pig-to-baboon and human ABO-incompatible renal transplantation.
    Kobayashi T; Yokoyama I; Nagasaka T; Liu D; Kato T; Tokoro T; Namii Y; Hayashi S; Nakao A; Morozumi K; Oikawa T; Usami T; Takeuchi O; Katayama A; Haba T; Tominaga Y; Uchida K; Takagi H
    Transplant Proc; 2000 Aug; 32(5):1097. PubMed ID: 10936374
    [No Abstract]   [Full Text] [Related]  

  • 14. Can ABO-incompatible organ transplantation pave the way for clinical xenotransplantation?
    Holgersson J
    Transplantation; 2007 Dec; 84(12 Suppl):S48-50. PubMed ID: 18162991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants.
    Fryer JP; Benedetti E; Perry EH; Matas AJ
    Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model.
    Cooper DK; Human PA; Rose AG; Rees J; Keraan M; Reichart B; Du Toit E; Oriol R
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):447-55. PubMed ID: 2645470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
    Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo?
    Takahashi K; Saito K; Nakagawa Y; Tasaki M; Hara N; Imai N
    Transplantation; 2010 Mar; 89(5):635-7. PubMed ID: 20216373
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: the baboon as a model for the human.
    Ye Y; Niekrasz M; Kehoe M; Rolf LL; Martin M; Baker J; Kosanke S; Romano E; Zuhdi N; Cooper DK
    Lab Anim Sci; 1994 Apr; 44(2):121-4. PubMed ID: 8028272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation.
    Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H
    Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.